A citation-based method for searching scientific literature

Yee Ming Lee, Keith Danahey, Randall W Knoebel, Mark J Ratain, David O Meltzer, Peter H O'Donnell. Pharmacogenet Genomics 2019
Times Cited: 4







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SNPs in cancer research and treatment.
H C Erichsen, S J Chanock. Br J Cancer 2004
132
50

Drug-drug-gene interactions and adverse drug reactions.
Mustafa Adnan Malki, Ewan Robert Pearson. Pharmacogenomics J 2020
27
50


Pharmacogenomics--drug disposition, drug targets, and side effects.
William E Evans, Howard L McLeod. N Engl J Med 2003
50

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
593
50

Understanding and preventing drug-drug and drug-gene interactions.
Cara Tannenbaum, Nancy L Sheehan. Expert Rev Clin Pharmacol 2014
66
50

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.
Raffaele Palmirotta, Claudia Carella, Erica Silvestris, Mauro Cives, Stefania Luigia Stucci, Marco Tucci, Domenica Lovero, Franco Silvestris. Oncotarget 2018
15
50

Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Dan M Roden, Sara L Van Driest, Jonathan D Mosley, Quinn S Wells, Jamie R Robinson, Joshua C Denny, Josh F Peterson. Clin Pharmacol Ther 2018
47
50

Pharmacogenomics.
Dan M Roden, Howard L McLeod, Mary V Relling, Marc S Williams, George A Mensah, Josh F Peterson, Sara L Van Driest. Lancet 2019
102
50

Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients.
Valentina Sini, Andrea Botticelli, Gianluigi Lunardi, Stefania Gori, Paolo Marchetti. Pharmacogenomics 2017
7
50

Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, Julianne P Hall, Aritro Nath, Dezheng Huo, Gini F Fleming, James N Ingle, Vandana G Abramson, P K Morrow,[...]. Breast Cancer Res Treat 2020
5
50

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, Didier Meulendijks, Geert W J Frederix, Emma Kienhuis, Geert-Jan Creemers, Arnold Baars, Vincent O Dezentjé, Alexander L T Imholz,[...]. Lancet Oncol 2018
121
25

Capecitabine and sixth cranial nerve palsy.
Sonali Dasgupta, Chineme Adilieje, Amlan Bhattacharya, Bruce Smith, Moeen ul Haq Sheikh. J Cancer Res Ther 2010
3
33

Potentially inappropriate medications in the elderly: the PRISCUS list.
Stefanie Holt, Sven Schmiedl, Petra A Thürmann. Dtsch Arztebl Int 2010
452
25


Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.
Anna D Wagner, Wilfried Grothe, Johannes Haerting, Gerhard Kleber, Axel Grothey, Wolfgang E Fleig. J Clin Oncol 2006
869
25

Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.
A B van Kuilenburg, J Haasjes, D J Richel, L Zoetekouw, H Van Lenthe, R A De Abreu, J G Maring, P Vreken, A H van Gennip. Clin Cancer Res 2000
284
25

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.
S T Pullarkat, J Stoehlmacher, V Ghaderi, Y P Xiong, S A Ingles, A Sherrod, R Warren, D Tsao-Wei, S Groshen, H J Lenz. Pharmacogenomics J 2001
359
25


FOLFOX versus FOLFIRI: a comparison of regimens in the treatment of colorectal cancer metastases.
Lara Maria Pasetto, Antonio Jirillo, Girolama Iadicicco, Elena Rossi, Myriam Katja Paris, Silvio Monfardini. Anticancer Res 2005
28
25

A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient.
Andrea Botticelli, Concetta E Onesti, Lidia Strigari, Mario Occhipinti, Francesca R Di Pietro, Bruna Cerbelli, Antonella Petremolo, Elisabetta Anselmi, Serena Macrini, Michela Roberto,[...]. Anticancer Drugs 2017
8
25

Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment.
Ronald J Maggiore, William Dale, Cary P Gross, Tao Feng, William P Tew, Supriya G Mohile, Cynthia Owusu, Heidi D Klepin, Stuart M Lichtman, Ajeet Gajra,[...]. J Am Geriatr Soc 2014
84
25


A Use Case to Support Precision Medicine for Frequently Hospitalized Older Adults with Polypharmacy.
Manuel Cabrera, Joseph Finkelstein. AMIA Jt Summits Transl Sci Proc 2016
5
25

Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant Capecitabine.
Michela Roberto, Adriana Romiti, Andrea Botticelli, Federica Mazzuca, Luana Lionetto, Giovanna Gentile, Ida Paris, Rosa Falcone, Maria Bassanelli, Francesca Romana Di Pietro,[...]. Eur J Clin Pharmacol 2017
9
25

Pharmacokinetic drug-drug interaction and their implication in clinical management.
Caterina Palleria, Antonello Di Paolo, Chiara Giofrè, Chiara Caglioti, Giacomo Leuzzi, Antonio Siniscalchi, Giovambattista De Sarro, Luca Gallelli. J Res Med Sci 2013
124
25

Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
Ali Alkan, Arzu Yaşar, Ebru Karcı, Elif Berna Köksoy, Muslih Ürün, Filiz Çay Şenler, Yüksel Ürün, Gülseren Tuncay, Hakan Ergün, Hakan Akbulut. Support Care Cancer 2017
32
25


Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
G J Peters, H H J Backus, S Freemantle, B van Triest, G Codacci-Pisanelli, C L van der Wilt, K Smid, J Lunec, A H Calvert, S Marsh,[...]. Biochim Biophys Acta 2002
261
25

Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection.
Massimiliano Berretta, Michele Caraglia, Ferdinando Martellotta, Silvia Zappavigna, Angela Lombardi, Carla Fierro, Luigi Atripaldi, Tommaso Muto, Daniela Valente, Paolo De Paoli,[...]. Front Pharmacol 2016
24
25

Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literature.
H A Bygrave, J I Geh, Y Jani, R Glynne-Jones. Clin Oncol (R Coll Radiol) 1998
15
25


5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX.
Concetta E Onesti, Andrea Botticelli, Marco La Torre, Marina Borro, Giovanna Gentile, Adriana Romiti, Luana Lionetto, Antonella Petremolo, Mario Occhipinti, Michela Roberto,[...]. Anticancer Drugs 2017
8
25

5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine.
Andrea Botticelli, Simone Scagnoli, Michela Roberto, Luana Lionetto, Bruna Cerbelli, Maurizio Simmaco, Paolo Marchetti. J Oncol Pharm Pract 2020
6
25

Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.
A Santos, S Zanetta, T Cresteil, A Deroussent, F Pein, E Raymond, L Vernillet, M L Risse, V Boige, A Gouyette,[...]. Clin Cancer Res 2000
172
25


Oculomotor disturbances associated with 5-fluorouracil chemotherapy.
W W Bixenman, J V Nicholls, O H Warwick. Am J Ophthalmol 1977
34
25


Polypharmacy cut-points in older people with cancer: how many medications are too many?
Justin P Turner, Kris M Jamsen, Sepehr Shakib, Nimit Singhal, Robert Prowse, J Simon Bell. Support Care Cancer 2016
73
25

Clinical Outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review.
Manvi Sharma, Aisha Vadhariya, Soumya Chikermane, Suma Gopinathan, Mariana Chavez-MacGregor, Sharon H Giordano, Michael L Johnson, Holly M Holmes. Drugs Aging 2019
10
25

A liquid chromatography-tandem mass spectrometry method for the determination of 5-Fluorouracil degradation rate by intact peripheral blood mononuclear cells.
Alfonso M Lostia, Luana Lionetto, Cristiano Ialongo, Giovanna Gentile, Antonella Viterbo, Paola Malaguti, Ida Paris, Luca Marchetti, Paolo Marchetti, Antonio De Blasi,[...]. Ther Drug Monit 2009
29
25

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
Anna D Wagner, Axel Grothey, Thierry Andre, Jesse G Dixon, Norman Wolmark, Daniel G Haller, Carmen J Allegra, Aimery de Gramont, Eric VanCutsem, Steven R Alberts,[...]. J Natl Cancer Inst 2021
10
25

A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy.
Joseph Ciccolini, Cédric Mercier, Alexandre Evrard, Laetitia Dahan, Jean-Christophe Boyer, Florence Duffaud, Karine Richard, Carmelo Blanquicett, Gérard Milano, Aurore Blesius,[...]. Ther Drug Monit 2006
65
25

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
Dan Rosmarin, Claire Palles, David Church, Enric Domingo, Angela Jones, Elaine Johnstone, Haitao Wang, Sharon Love, Patrick Julier, Claire Scudder,[...]. J Clin Oncol 2014
151
25

A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness.
Raziyeh Kheshti, Mohammadsadegh Aalipour, Soha Namazi. J Res Pharm Pract 2016
64
25

Effect of CYP2D6 Poor Metabolizer Phenotype on Stereoselective Nebivolol Pharmacokinetics.
Carolina P Vieira, Daniel V Neves, Eduardo B Coelho, Vera Lucia Lanchote. Drug Metab Lett 2018
3
33

Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
Arjun P Athreya, Drew Neavin, Tania Carrillo-Roa, Michelle Skime, Joanna Biernacka, Mark A Frye, A John Rush, Liewei Wang, Elisabeth B Binder, Ravishankar K Iyer,[...]. Clin Pharmacol Ther 2019
34
25

Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Marco Proietti, Imma Romanazzi, Giulio Francesco Romiti, Alessio Farcomeni, Gregory Y H Lip. Stroke 2018
52
25

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.
Joshua P Lewis, Richard B Horenstein, Kathleen Ryan, Jeffrey R O'Connell, Quince Gibson, Braxton D Mitchell, Keith Tanner, Sumbul Chai, Kevin P Bliden, Udaya S Tantry,[...]. Pharmacogenet Genomics 2013
99
25

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
226
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.